Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Selina Shiqing K. Teh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5281-1978; OpenAlex author ID A5070123106. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

  1. Simultaneous CRISPR/Cas9-induced double-strand breaks are lethal in models of pancreatic cancer. Co-author DOI 10.1172/jci190121↗
  2. Semaphorin 3D promotes pancreatic ductal adenocarcinoma progression and metastasis through macrophage reprogramming. Co-author DOI 10.1126/sciadv.adp0684↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Robert A. Anders · 1 shared paper, 2026 · strength 0.23
  2. Nicholas Jason Roberts · 1 shared paper, 2026 · strength 0.23
  3. James R. Eshleman · 1 shared paper, 2026 · strength 0.23
  4. Ralph H. Hruban · 1 shared paper, 2026 · strength 0.23
  5. Kenji Fujiwara · 1 shared paper, 2024 · strength 0.17
  6. Wei‐Chih Sun · 1 shared paper, 2024 · strength 0.17
  7. Stephen T. Muth · 1 shared paper, 2024 · strength 0.17
  8. Keyu Li · 1 shared paper, 2024 · strength 0.17
  9. Xingyi Pan · 1 shared paper, 2024 · strength 0.17
  10. Elizabeth M. Jaffee · 1 shared paper, 2024 · strength 0.17
  11. Lei Zheng · 1 shared paper, 2024 · strength 0.17
  12. Noelle R. J. Thielman · 1 shared paper, 2024 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.